These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 816167)

  • 1. Proceedings: Pharmacological properties of a new oral long-acting neuroleptic drug penfluridol.
    Metys J; Dlavac A; Kazdová E
    Act Nerv Super (Praha); 1975; 17(4):219-20. PubMed ID: 816167
    [No Abstract]   [Full Text] [Related]  

  • 2. Interspecies differences in sensitivity to the neuroleptic drug penfluridol.
    Metys J; Dlabac A
    Act Nerv Super (Praha); 1977 Jul; 19 Suppl 2():337-8. PubMed ID: 551646
    [No Abstract]   [Full Text] [Related]  

  • 3. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Wauquier A
    Arzneimittelforschung; 1975 Aug; 25(8):1287-94. PubMed ID: 1242360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological studies of an antipschotic agent, penfluridol. (1). The central pharmacological actions].
    Ito K; Nurimoto S; Shintomi K; Kowa Y; Yamamura M; Ishida R
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):795-813. PubMed ID: 828132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penfluridol blockade of apomorphine: dependence of duration on species and endpoint.
    Weissman A
    Eur J Pharmacol; 1975; 33(2):267-75. PubMed ID: 1237408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of penfluridol and other drugs on apomorphine-induced stereotyped behavior in monkeys.
    Shintomi K; Yamamura M
    Eur J Pharmacol; 1975 Apr; 31(2):273-80. PubMed ID: 1171014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative effects of penfluridol, a long-acting neuroleptic drug, as assayed by its behavioral actions.
    Kuribara H; Tadokoro S
    Jpn J Pharmacol; 1976 Dec; 26(6):693-702. PubMed ID: 1021605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of antiemetic action of penfluridol in the dog.
    Lee HK; Chung PM; Wang SC
    Eur J Pharmacol; 1978 Dec; 53(1):29-38. PubMed ID: 738357
    [No Abstract]   [Full Text] [Related]  

  • 9. Penfluridol: once-a-week oral maintenance neuroleptic in the management of chronic schizophrenics.
    Kurland AA; Ota KY
    Psychopharmacol Bull; 1975 Jan; 11(1):12-4. PubMed ID: 1091943
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biological fate of 3H-labeled penfluridol. (3) Correlation between concentration of 3H-penfluridol in the brain and its anti-methamphetamine activity].
    Nakamura S; Ishida R; Sugihara J
    Radioisotopes; 1976 Oct; 25(10):637-40. PubMed ID: 1037406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The central nervous system pharmacology of an anti-emetic dihydroindolone derivative.
    Holmes SW; Gylys JA
    Arzneimittelforschung; 1973 Sep; 23(9):1314-8. PubMed ID: 4204318
    [No Abstract]   [Full Text] [Related]  

  • 12. Penfluridol: a neuroleptic drug designed for long duration of action.
    Migdalof BH; Grindel JM; Heykants JJ; Janssen PA
    Drug Metab Rev; 1979; 9(2):281-99. PubMed ID: 385274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of penfluridol (R 16341) a new potent and orally long-acting neuroleptic drug.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Verbruggen FJ; Van Nueten JM; Schaper WK
    Eur J Pharmacol; 1970 Jul; 11(2):139-54. PubMed ID: 5447800
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
    Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
    Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
    [No Abstract]   [Full Text] [Related]  

  • 16. 5-Methoxy-N,N-dimethyltryptamine: behavioral and toxicological effects in animals.
    Gillin JC; Tinklenberg J; Stoff DM; Stillman R; Shortlidge JS; Wyatt RJ
    Biol Psychiatry; 1976 Jun; 11(3):355-8. PubMed ID: 820383
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. IV. Antiadrenergic action and influence on brain monoamines.
    Dlabac A; Metys J; Metysová J
    Act Nerv Super (Praha); 1971; 13(3):188-9. PubMed ID: 5113833
    [No Abstract]   [Full Text] [Related]  

  • 18. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
    Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
    Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptake.
    Ortmann R; Radeke E; Buech O; Sigg K; Rogg H; Glatt A; Truog A; Jaekel J; Everitt BJ; Delini-Stula A
    Arzneimittelforschung; 1986 Dec; 36(12):1727-32. PubMed ID: 3566833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electroencephalographic picture in patients treated with penfluridol].
    Zapletálek M; Hanus H; Kindernayová H; Stránský P; Valach M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1978; 21(5):573-8. PubMed ID: 292136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.